Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00223-013-9774-y.

Title:
Osteocyte-Driven Bone Remodeling | Calcified Tissue International
Description:
Osteocytes, the most abundant cells in bone, have been long postulated to detect and respond to mechanical and hormonal stimuli and to coordinate the function of osteoblasts and osteoclasts. The discovery that the inhibitor of bone formation sclerostin is primarily expressed in osteocytes in bone and downregulated by anabolic stimuli provided a mechanism by which osteocytes influence the activity of osteoblasts. Advances of the last few years provided experimental evidence demonstrating that osteocytes also participate in the recruitment of osteoclasts and the initiation of bone remodeling. Apoptotic osteocytes trigger yet-to-be-identified signals that attract osteoclast precursors to specific areas of bone, which in turn differentiate to mature, bone-resorbing osteoclasts. Osteocytes are also the source of molecules that regulate the generation and activity of osteoclasts, such as OPG and RANKL; and genetic manipulations of the mouse genome leading to loss or gain of function or to altered expression of either molecule in osteocytes markedly affect bone resorption. This review highlights these investigations and discusses how the novel concept of osteocyte-driven bone resorption and formation impacts our understanding of the mechanisms by which current therapies control bone remodeling.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 8,170,536 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

bone, pubmed, google, scholar, article, cas, osteocyte, bellido, central, osteocytes, res, miner, cell, apoptosis, plotkin, sclerostin, signaling, remodeling, manolagas, mechanical, formation, biol, parfitt, estrogen, weinstein, control, mice, obrien, chem, osteoblasts, loss, jilka, clin, receptor, noble, tissue, osteoclasts, resorption, chapter, osteoblast, pth, van, sost, allen, han, privacy, cookies, function, content, teresita,

Topics {✒️}

caveolin-1/extracellular signal–regulated kinase month download article/chapter wnt/lrp5 receptor-independent activation antagonizing wnt/beta-catenin signaling osteocyte wnt/beta-catenin signaling osteocyte-driven bone remodeling osteocyte-driven bone resorption osteocytic perilacunar/canalicular remodeling gap junction–independent action e11/gp38 selective expression wnt/beta-catenin signaling active pro-osteoclastogenic signaling ß-catenin survival pathways wnt/β-catenin signaling estrogen receptor α-mediated van bezooijen rl fatigue-loaded bone involves osteocyte-expressed negative regulator full article pdf metalloproteinase mt1-mmp bonewald lf attract osteoclast precursors privacy choices/manage cookies β-catenin signaling aguirre ji armstrong vj beta-catenin-dependent van buchem disease inhibits bone formation periosteal bone formation intra-cortical remodeling precedes osteoclast recruitment nontargeted bone remodeling local wnt signaling jilka rl review highlights winkler dg rankl subcellular trafficking circulating sclerostin levels shear stress inhibits biphasic osteocyte survival distinct osteocyte populations src/erk pathway pth receptor signaling bone remodeling regulation abrupt estrogen withdrawal article bellido increased bone density anabolic stimuli provided uncommitted osteoblast progenitors

Questions {❓}

  • Verborgt O, Tatton NA, Majeska RJ, Schaffler MB (2002) Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Osteocyte-Driven Bone Remodeling
         description:Osteocytes, the most abundant cells in bone, have been long postulated to detect and respond to mechanical and hormonal stimuli and to coordinate the function of osteoblasts and osteoclasts. The discovery that the inhibitor of bone formation sclerostin is primarily expressed in osteocytes in bone and downregulated by anabolic stimuli provided a mechanism by which osteocytes influence the activity of osteoblasts. Advances of the last few years provided experimental evidence demonstrating that osteocytes also participate in the recruitment of osteoclasts and the initiation of bone remodeling. Apoptotic osteocytes trigger yet-to-be-identified signals that attract osteoclast precursors to specific areas of bone, which in turn differentiate to mature, bone-resorbing osteoclasts. Osteocytes are also the source of molecules that regulate the generation and activity of osteoclasts, such as OPG and RANKL; and genetic manipulations of the mouse genome leading to loss or gain of function or to altered expression of either molecule in osteocytes markedly affect bone resorption. This review highlights these investigations and discusses how the novel concept of osteocyte-driven bone resorption and formation impacts our understanding of the mechanisms by which current therapies control bone remodeling.
         datePublished:2013-09-04T00:00:00Z
         dateModified:2013-09-04T00:00:00Z
         pageStart:25
         pageEnd:34
         sameAs:https://doi.org/10.1007/s00223-013-9774-y
         keywords:
            Osteocyte
            Osteoclast
            Osteoblast
            Bone remodeling
            RANKL
            OPG
            Sost
            Biochemistry
            general
            Endocrinology
            Orthopedics
            Cell Biology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-013-9774-y/MediaObjects/223_2013_9774_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-013-9774-y/MediaObjects/223_2013_9774_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-013-9774-y/MediaObjects/223_2013_9774_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-013-9774-y/MediaObjects/223_2013_9774_Fig4_HTML.gif
         isPartOf:
            name:Calcified Tissue International
            issn:
               1432-0827
               0171-967X
            volumeNumber:94
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Teresita Bellido
               affiliation:
                     name:Indiana University School of Medicine
                     address:
                        name:Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
                     name:Indiana University School of Medicine
                     address:
                        name:Division of Endocrinology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
                     name:Roudebush Veterans Administration Medical Center
                     address:
                        name:Roudebush Veterans Administration Medical Center, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Osteocyte-Driven Bone Remodeling
      description:Osteocytes, the most abundant cells in bone, have been long postulated to detect and respond to mechanical and hormonal stimuli and to coordinate the function of osteoblasts and osteoclasts. The discovery that the inhibitor of bone formation sclerostin is primarily expressed in osteocytes in bone and downregulated by anabolic stimuli provided a mechanism by which osteocytes influence the activity of osteoblasts. Advances of the last few years provided experimental evidence demonstrating that osteocytes also participate in the recruitment of osteoclasts and the initiation of bone remodeling. Apoptotic osteocytes trigger yet-to-be-identified signals that attract osteoclast precursors to specific areas of bone, which in turn differentiate to mature, bone-resorbing osteoclasts. Osteocytes are also the source of molecules that regulate the generation and activity of osteoclasts, such as OPG and RANKL; and genetic manipulations of the mouse genome leading to loss or gain of function or to altered expression of either molecule in osteocytes markedly affect bone resorption. This review highlights these investigations and discusses how the novel concept of osteocyte-driven bone resorption and formation impacts our understanding of the mechanisms by which current therapies control bone remodeling.
      datePublished:2013-09-04T00:00:00Z
      dateModified:2013-09-04T00:00:00Z
      pageStart:25
      pageEnd:34
      sameAs:https://doi.org/10.1007/s00223-013-9774-y
      keywords:
         Osteocyte
         Osteoclast
         Osteoblast
         Bone remodeling
         RANKL
         OPG
         Sost
         Biochemistry
         general
         Endocrinology
         Orthopedics
         Cell Biology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-013-9774-y/MediaObjects/223_2013_9774_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-013-9774-y/MediaObjects/223_2013_9774_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-013-9774-y/MediaObjects/223_2013_9774_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-013-9774-y/MediaObjects/223_2013_9774_Fig4_HTML.gif
      isPartOf:
         name:Calcified Tissue International
         issn:
            1432-0827
            0171-967X
         volumeNumber:94
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Teresita Bellido
            affiliation:
                  name:Indiana University School of Medicine
                  address:
                     name:Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
                  name:Indiana University School of Medicine
                  address:
                     name:Division of Endocrinology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
                  name:Roudebush Veterans Administration Medical Center
                  address:
                     name:Roudebush Veterans Administration Medical Center, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Calcified Tissue International
      issn:
         1432-0827
         0171-967X
      volumeNumber:94
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Indiana University School of Medicine
      address:
         name:Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Indiana University School of Medicine
      address:
         name:Division of Endocrinology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Roudebush Veterans Administration Medical Center
      address:
         name:Roudebush Veterans Administration Medical Center, Indianapolis, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Teresita Bellido
      affiliation:
            name:Indiana University School of Medicine
            address:
               name:Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
            name:Indiana University School of Medicine
            address:
               name:Division of Endocrinology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
            name:Roudebush Veterans Administration Medical Center
            address:
               name:Roudebush Veterans Administration Medical Center, Indianapolis, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, USA
      name:Division of Endocrinology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA
      name:Roudebush Veterans Administration Medical Center, Indianapolis, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(284)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.33s.